ADAGE CAPITAL PARTNERS GP LLC 13D and 13G filings for Inozyme Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-07 07:46 am Purchase |
2023-12-31 | 13G | Inozyme Pharma, Inc. INZY |
ADAGE CAPITAL PARTNERS GP LLC | 5,537,500 8.970% |
2,437,362 (+78.62%) |
Filing |
| 2023-02-09 11:43 am Purchase |
2022-12-31 | 13G | Inozyme Pharma, Inc. INZY |
ADAGE CAPITAL PARTNERS GP LLC | 3,100,138 7.670% |
1,501,110 (+93.88%) |
Filing |
| 2022-02-10 09:22 am Purchase |
2021-12-31 | 13G | Inozyme Pharma, Inc. INZY |
ADAGE CAPITAL PARTNERS GP LLC | 1,599,028 6.760% |
310,356 (+24.08%) |
Filing |
| 2021-05-10 4:05 pm Purchase |
2021-04-29 | 13G | Inozyme Pharma, Inc. INZY |
ADAGE CAPITAL PARTNERS GP LLC | 1,288,672 5.490% |
1,288,672 (New Position) |
Filing |